Skip to content
2000
Volume 11, Issue 8
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

17α-Hydroxylase/17,20-lyase is a target in the treatment of hormone-dependent prostate cancer. Here we report the results of a study into a range of alkanesulfonate derivatives of 4-hydroxybenzylimidazole which show the compounds to be good inhibitors with 5 [IC50=1.11μM (17α-OHase) and IC50=1.28μM (lyase)] being the most potent but weaker than ketoconazole.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180811666131230235538
2014-10-01
2025-06-14
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180811666131230235538
Loading

  • Article Type:
    Research Article
Keyword(s): 17α-hydroxylase/17; 17α-OHase; 20-lyase; Azole; Inhibitors Lyase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test